semaglutide thuốc Thông tin thuốc semaglutide trị

Given the results of the GRADE study and our recent findings suggesting that persistence with GLP-1 RA is associated with better glycemic control than DPP4i, a need exists to understand the comparative durability of the new-generation GLP-1 RA semaglutide and the commonly used glucose-lowering agent class DPP4i in the real-world setting

(2024, January 10)

To benefit from semaglutide most, individuals should always consult with their healthcare professional before starting or adjusting dosages when needed

Many patients choose this route to avoid prolonged uncertainty while maintaining the option to transition to insurance coverage if the appeal succeeds later

No data on effects on breastfed infants